Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
l Department of Clinical Psychology, VU University Amsterdam, Van der Boechorststraat 1,1081 BT Amsterdam, The Netherlands; 2EMGO Institute for Health and Care Research, VU University and VU University Medical Center, Amsterdam, The Netherlands; 3Leuphana University, Lunebrug, Germany; 4Department of Behavioural Sciences and Learning, Swedish Institute for Disability Research, University of Linkoping, Sweden; 5Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet, Stockholm, Sweden; 6Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands; 7Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Список исп. литературыСкрыть список
. Kessler RC, Berglund P, Demler O et al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-105.
2. Kessler RC, Berglund P, Demler O et al. Lifetime prevalence and age- of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593-602.
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
4. Berto P, D’Ilario D, Ruffo P et al. Depression: cost-of-illness studies in the international literature: a review. J Ment Health Policy Econ 2000;3:3-10.
5. Greenberg PE, Birnbaum HG. The economic burden of depression in the US: societal and patient perspectives. Exp Opin Pharmacother 2005;6:369-76.
6. Smit F, Cuijpers P, Oostenbrink J et al. Excess costs of common mental disorders: population based cohort study. J Ment Health Policy Econ 2006; 9:193-200.
7. Ustun TB, Ayuso-Mateos JL, Chatterji S et al. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004;184:386-92.
8. Saarni SI, Suvisaari J, Sintonen H et al. Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry 2007;190:326-32.
9. National Institute for Health and Clinical Excellence (NICE). Depression; the treatment and management of depression in adults. National Institute for Health and Clinical Excellence: Holborn, 2009.
10. Bauer M, Bschor T, Pfennig A et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry 2007;8:67-104.
11. Bandelow B, Sher L, Bunevicius R et al. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract 2012;16:77-84.
12. Cuijpers P, van Straten A, van Oppen P et al. Are psychological and pharmacological interventions equally effective in the treatment of adult depressive disorders? A meta-analysis of comparative studies. J Clin Psychiatry 2008;69:1675-85.
13. Mitte K. Meta-analysis of cognitive-behavioral treatments for generalized anxiety disorder: a comparison with pharmacotherapy. Psychol Bull 2005;131:785-95.
14. Spielmans GI, Berman MI, Usitalo AN. Psychotherapy versus second-generation antidepressants in the treatment of depression; a meta-analysis. J NervMent Dis 2011;199:142-9.
15. Cuijpers P, van Straten A, Andersson G et al. Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J Consult Clin Psychol 2008;76:909-22.
16. Barth J, Munder T, Gerger H et al. Comparative efficacy of seven psychotherapeutic interventions for depressed patients: results of a network meta-analysis. Submitted for publication.
17. Cuijpers P, Geraedts AS, van Oppen P et al. Interpersonal psychotherapy of depression: a meta-analysis. Am J Psychiatry 2011;168:581-92.
18. Driessen E, Cuijpers P, de Maat SCM et al. The efficacy of shortterm psychodynamic psychotherapy for depression: a meta-analysis. Clin Psychol Rev 2010;30:25-36.
19. Cuijpers P, Driessen E, Hollon SD et al. The efficacy of non-directive supportive therapy for adult depression: a meta-analysis. Clin Psychol Rev 2010;32:280-91.
20. Higgins JPT, Green S (eds). Cochrane handbook for systematic reviews of interventions. Version 5.0.1. Cochrane Collaboration, 2008.
21. Hedges LV, Olkin I. Statistical methods for meta-analysis. San Diego: Academic Press, 1985.
22. Higgins JP, Thompson SG, Deeks JJ et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
23. Ioannidis JPA, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ 2007;335:914-6.
24. Orsini N, Higgins J, Bottai M et al. Heterogi: Stata module to quantify heterogeneity in a meta-analysis. Boston: Boston College Department of Economics, 2005.
25. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56:455-63.
26. Bakhshani NM, Lashkaripour K, Sadjadi SA. Effectiveness of short term cognitive behavior therapy in patients with generalized anxiety disorder. J Med Sci 2007;7:1076-81.
27. Bakker A, van Dyck R, Spinhoven P et al. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder. J Clin Psychiatry 1999;60:831-8.
28. Barber J, Barrett MS, Gallop R et al. Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial. J Clin Psychiatry 2012;73:66-73.
29. Barlow DH, Gorman JM, Shear MK et al. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA 2000;283:2529-36.
30. Barrett JE, Williams JW, Oxman TE et al. Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years. J Fam Pract 2001:50:405-12.
31. Bedi N, Chilvers C, Churchill R et al. Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. Br J Psychiatry 2000;177:312-8.
32. Black DW, Wesner R, Bowers W et al. A comparison of fluvox- amine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry 1993;50:44-50.
33. Blackburn IM, Moore RG. Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with current depression. Br J Psychiatry 1997;171:328-34.
34. Blanco C, Heimberg RG, Schneier FR et al. A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder. Arch Gen Psychiatry 2010; 67:286-95.
35. Blomhoff S, Haug TT, Hellstrom K et al. Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia. Br J Psychiatry 2001;179:23- 30.
36. Browne G, Steiner M, Roberts J et al. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. J Affect Dis 2002;68:317-30.
37. Clark DM, Salkovskis PM, Hackman A et al. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry 1994;164:759-69.
38. Dannon PN, Gon-Usishkin M, Gelbert A et al. Cognitive behavioral group therapy in panic disorder patients: the efficacy of CBGT versus drug treatment. Ann Clin Psychiatry 2004;16:41-6.
39. David D, Szentagotai A, Lupu V et al. Rational emotive behavior therapy, cognitive therapy, and medication in the treatment of major depressive disorder: a randomized clinical trial, posttreatment outcomes, and six-month follow-up. J Clin Psychol 2008;64:728-46.
40. Davidson JRT, Foa EB, Huppert JD et al. Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Arch Gen Psychiatry 2004;61:1005-13.
41. Dekker JJM, Koelen JA, Van HL et al. Speed of action: the relative efficacy of short psychodynamic supportive psychotherapy and pharmacotherapy in the first 8 weeks of a treatment algorithm for depression. J Affect Disord 2008;109:183-8.
42. Dunlop BW, Kelley ME, Mletzko TC et al. Depression beliefs, treatment preference, and outcomes in a randomized trial for major depressive disorder. J Psychiatr Res 2012;46:375-81.
43. Dunner DL, Schmaling KB, Hendrickson H et al. Cognitive therapy versus fluoxetine in the treatment of dysthymic disorder. Depression 1996;4:34-41.
44. Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry 1989;46:
45. Faramarzi M, Alipor A, Esmaelzadeh S et al. Treatment of depression and anxiety in infertile women: cognitive behavioral therapy versus fluoxetine. J Affect Disord 2008;108:159-64.
46. Finkenzeller W, Zobel I, Rietz S et al. Interpersonal psychotherapy and pharmacotherapy for post-stroke depression. Feasibility and effectiveness. Nervenarzt 2009;80:805-12.
47. Foa EB, Liebowitz MR, Kozak MJ et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. AmJ Psychiatry2005;162: 151-61.
48. Frank E, Cassano GB, Rucci P et al. Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy. Psychol Med 2011;41:151-62.
49. Frommberger U, Stieglitz RD, Nyberg E et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int J Psychiatry Clin Pract 2004; 8:19-23.
50. Hegerl U, Hautzinger M, Mergl R et al. Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients’ choice arm. Int J Neuropsychopharmacol 2010;13:31-44.
51. Heimberg RG, Liebowitz MR, Hope DA et al. Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. Arch Gen Psychiatry 1998;55: 1133-41.
52. Hendriks GJ, Keijsers GP, Kampman M et al. A randomized controlled study of paroxetine and cognitive-behavioural therapy for late-life panic disorder. Acta Psychiatr Scand 2010;122:11-9.
53. Hoexter MQ, de Souza Duran FL, D’Alcante CC et al. Gray matter volumes in obsessive-compulsive disorder before and after fluoxetine or cognitive-behavior therapy: a randomized clinical trial. Neuropsychopharmacology 2012;37:734-45.
54. Hollon SD, DeRubeis RJ, Evans MD et al. Cognitive therapy and pharmacotherapy for depression: singly and in combination. Arch Gen Psychiatry 1992;49:774-81.
55. Jarrett RB, Schaffer M, McIntire D et al. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999;56:431-7.
56. Keller MB, McCullough JP, Klein DN et al. A comparison of ne- fazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000;342:1462-70.
57. Kolk BA, Spinazzola J, Blaustein ME et al. A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry 2007;68:37-46.
58. Koszycki D, Taljaard M, Segal S et al. A randomized trial of sertraline, self-administered cognitive behavior therapy, and their combination for panic disorder. Psychol Med 2011;41:373-83.
59. Lesperance F, Frasure-Smith N, Koszycki D et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007;297:367-79.
60. Loerch B, Graf-Morgenstern M, Hautzinger M et al. Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia. Br J Psychiatry 1999;174:205-12.
61. Markowitz JC, Kocsis JH, Bleiberg KL et al. A comparative trial of psychotherapy and pharmacotherapy for "pure" dysthymic patients. J Affect Disord 2005;89:167-75.
62. Marshall MB, Zuroff DC, McBride C et al. Self-criticism predicts differential response to treatment for major depression. J Clin Psychol 2008;64:231-44.
63. Martin SD, Martin E, Rai SS et al. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Arch Gen Psychiatry 2001;58:641-8.
64. McBride C, Segal Z, Kennedy S et al. Changes in autobiographical memory specificity following cognitive behavior therapy and pharmacotherapy for major depression. Psychopathology 2007;40:147-52.
65. McKnight DL, Nelson-Gray RO, Barnhill J. Dexamethasone suppression test and response to cognitive therapy and antidepressant medication. Behav Ther 1992;1:99-111.
66. McLean PD, Hakstian AR. Clinical depression: comparative efficacy of outpatient treatments. J Consult Clin Psychol 1979;47:818-36.
67. Miranda J, Chung JY, Green BL et al. Treating depression in predominantly low-income young minority women: a randomized controlled trial. JAMA 2003;290:57-65.
68. Mohr DC, Boudewyn AC, Goodkin DE et al. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 2001;69: 942-9.
69. Mortberg E, Clark DM, Sundin O et al. Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia: a randomized controlled trial. Acta Psychiatr Scand 2007;115:142-54.
70. Murphy GE, Simons AD, Wetzel RD et al. Cognitive therapy and pharmacotherapy. Singly and together in the treatment of depression. Arch Gen Psychiatry 1984;41:33-41.
71. Murphy GE, Carney RM, Knesevich MA et al. Cognitive behavior therapy, relaxation training and tricyclic antidepressant medication in the treatment of depression. Psychol Rep 1995;77:403-20.
72. Mynors-Wallis LM, Gath DH, Day A et al. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ 2000;320:26-30.
73. Nakatani E, Nakagawa A, Nakao T et al. A randomized controlled trial of Japanese patients with obsessive-compulsive disorder – effectiveness of behavior therapy and fluvoxamine. Psychother Psychosom 2005;74:269-76.
74. Nazari H, Momeni N, Jariani M et al. Comparison of eye movement desensitization and reprocessing with citalopram in treatment of obsessive-compulsive disorder. Int J Psychiatry Clin Pract 2011;15:270-4.
75. Oosterbaan DB, van Balkom AJLM, Spinhoven P et al. Cognitive therapy versus moclobemide in social phobia: a controlled study. Clin Psychol Psychother 2001;8:263-73.
76. Prasko J, Dockery C, Horacek J et al. Moclobemide and cognitive behavioral therapy in the treatment of social phobia. A six-month controlled study and 24 months follow up. Neuroendocrinol Lett 2006;27:473-81.
77. Ravindran AV, Anisman H, Merali Z et al. Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments. Am J Psychiatry 1999;156:1608-17.
78. Reynolds CF, Miller MD, Pasternak RE et al. Treatment of bereavement-related major depressive episodes in later life: a controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy. Am J Psychiatry 1999;156:202-8.
79. Rush AJ, Beck AT, Kovacs M et al. Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients. CognTher Res 1977;1:17-38.
80. Salminen JK, Karlsson H, HietalaJ etal. Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study. Psychother Psychosom 2008;77: 351-7.
81. Schulberg HC, Block MR, Madonia MJ et al. Treating major depression in primary care practice. Eight-month clinical outcomes. Arch Gen Psychiatry 1996;53:913-9.
82. Scott AI, Freeman CP. Edinburgh primary care depression study: treatment outcome, patient satisfaction, and cost after 16 weeks. BMJ 1992;304:883-7.
83. Shamsaei F, Rahimi A, Zarabian MK et al. Efficacy of pharmacotherapy and cognitive therapy, alone and in combination in major depressive disorder. Hong Kong J Psychiatry 2008;18:76-80.
84. Shareh H, Gharraee B, Atef-Vahid MK et al. Metacognitive therapy (MCT), fluvoxamine, and combined treatment in improving obsessive-compulsive, depressive and anxiety symptoms in patients with obsessive-compulsive disorder (OCD). Iran J Psychiatry Behav Sci 2010;4:17-25.
85. Sharp DM, Power KG, Simpson RJ et al. Fluvoxamine, placebo, and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia. J Anxiety Disord 1996;10;219-42.
86. Sharp DJ, Chew-Graham C, Tylee A et al. A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial. Health Technol Assess 2010;14:43.
87. Sousa MB, Isolan LR, Oliveira RR et al. A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive compulsive disorder. J Clin Psychiatry 2006;67:1133-9.
88. Spinhoven P, Onstein EJ, Klinkhamer RA et al Panic management, trazodone and a combination of both in the treatment of panic disorder. Clin Psychol Psychother 1996;3:86-92.
89. Thompson LW, Coon DW, Gallagher-Thompson D et al. Comparison of desipramine and cognitive/behavioral therapy in the treatment of elderly outpatients with mild-to-moderate depression. Am J Geriatr Psychiatry 2001;9:225-40.
90. van Apeldoorn FJ, van Hout WJPJ, Mersch PPA et al. Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia. Acta Psychiatr Scand 2008;117:260-70.
91. Weissman MM, Prusoff BA, Dimascio A et al. The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes. Am J Psychiatry 1979;136:555-8.
92. Williams JW, Barrett J, Oxman T et al. Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults. JAMA 2000;284:1519-26.
93. Cuijpers P, Driessen E, Hollon SD et al. The efficacy of non-directive supportive therapy for adult depression: a meta-analysis. Clin Psychol Rev 2010;32:280-91.
94. Cuijpers P, van Straten A, Schuurmans J et al. Psychotherapy for chronic major depression and dysthymia: a meta-analysis. Clin Psychol Rev 2010;30:51-62.
95. Imel ZE, Malterer MB, McKay KM et al. A meta-analysis of psychotherapy and medication in unipolar depression and dysthymia. J Affect Disord 2008;110:197-206.
96. Barlow DH. Negative effects from psychological treatments. Am Psychol 2010;65:13-20.
Поделиться ссылкой на выделенное